- Report
- August 2025
- 194 Pages
Global
From €3127EUR$3,545USD£2,740GBP
€3474EUR$3,939USD£3,044GBP
- Report
- November 2025
- 181 Pages
Global
From €3127EUR$3,545USD£2,740GBP
€3474EUR$3,939USD£3,044GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2117EUR$2,400USD£1,855GBP
€2646EUR$3,000USD£2,318GBP
- Report
- June 2025
- 150 Pages
Global
From €2381EUR$2,699USD£2,086GBP
- Report
- April 2025
- 137 Pages
Asia Pacific
From €3043EUR$3,450USD£2,666GBP
- Report
- April 2025
- 136 Pages
Africa, Middle East
From €3043EUR$3,450USD£2,666GBP
- Report
- May 2024
- 131 Pages
Global
From €4872EUR$5,524USD£4,269GBP
€5732EUR$6,499USD£5,022GBP
- Report
- May 2024
- 132 Pages
Global
From €4872EUR$5,524USD£4,269GBP
€5732EUR$6,499USD£5,022GBP
- Report
- October 2023
- 145 Pages
Global
From €2778EUR$3,150USD£2,434GBP
- Report
- April 2023
- 180 Pages
Global
From €2293EUR$2,600USD£2,009GBP
€2867EUR$3,250USD£2,512GBP
- Report
- August 2024
- 80 Pages
Japan
From €3087EUR$3,500USD£2,705GBP
- Report
- May 2024
- 132 Pages
Global
From €4872EUR$5,524USD£4,269GBP
€5732EUR$6,499USD£5,022GBP
- Report
- February 2024
- 360 Pages
Global
From €5610EUR$6,360USD£4,915GBP
€7012EUR$7,950USD£6,144GBP
- Report
- December 2023
- 140 Pages
Global
From €3925EUR$4,450USD£3,439GBP
- Report
- July 2024
- 150 Pages
Global
From €3925EUR$4,450USD£3,439GBP
- Report
- November 2020
- 199 Pages
Global
€3969EUR$4,500USD£3,478GBP
- Report
- December 2025
- 50 Pages
Global
From €2337EUR$2,650USD£2,048GBP

Bimatoprost is a medication used to treat glaucoma and other optical disorders. It is a prostaglandin analog, meaning it works by increasing the outflow of fluid from the eye, reducing intraocular pressure. Bimatoprost is available as a topical ophthalmic solution, and is the only prostaglandin analog approved for the treatment of glaucoma and ocular hypertension. It is also used to treat hypotrichosis, a condition characterized by inadequate or thinning eyelashes.
Bimatoprost is a widely used medication in the optical disorders drugs market. It is the most commonly prescribed prostaglandin analog for glaucoma and ocular hypertension, and is also used off-label for other conditions. Bimatoprost is generally well-tolerated, with few side effects.
Some companies in the Bimatoprost market include Allergan, Sun Pharmaceuticals, and Pfizer. Show Less Read more